New FDA guid­ance gives man­u­fac­tur­ers lim­its for ni­trosamines

Af­ter as­sess­ing com­ments from in­dus­try play­ers, the FDA has fi­nal­ly is­sued its fi­nal guid­ance with rec­om­men­da­tions on ac­cept­able in­take lim­its for ni­trosamine im­pu­ri­ties in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland